RG6209
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 13, 2026
Pregonda: A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
(clinicaltrials.gov)
- P1 | N=151 | Active, not recruiting | Sponsor: Genentech, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Diabetic Macular Edema • Ophthalmology
1 to 1
Of
1
Go to page
1